Swiss Connection Reception

Dr. Felix Spindler Presents A Case Study On High Throughput Catalysis Screening.

Event Details

Date

September 30, 2014 from 6:30 pm to 9:00 pm Pacific/Easter (UTC-05:00)

swissnex Boston invites you to a Swiss Reception offered by Solvias AG and RohnerChem AG. 

Representatives of Solvias and Rohner will be in Cambridge for their annual “Swiss Connection Reception”.  Ronald Yarger and Jim Schwindeman will present brief overviews of their company’s drug development and manufacturing services. Dr. Felix Spindler, Team Leader of the Catalysis Group at Solvias, will be present for discussions on High Throughput Catalysis Screens. This talk will be followed by a reception of tasty refreshments, Swiss wine, and bakery delights at swissnex Boston, the Swiss Consulate.  


Program:

  • Introduction
    • Niccolo Iorno, Project Manager | swissnex Boston
  • Solvias: Navigate Your Project to Success
    • Dr. Ronald Yarger, Head of North American Sales | Solvias, Inc.
  • RohnerChem: 100 Years of Swiss Manufacturing Excellence
    • Dr. James Schwindeman, Executive VP | Rohner, Inc.
  • HTS of Catalysts: Emphasis on Handling Potent Compounds
    • Dr. Felix Spindler, Team Leader of the Catalysis Group | Solvias, Inc.


About Solvias: 


Solvias, based near Basel, Switzerland, offers extensive chemical and analytical development services for pharmaceutical and life sciences companies.  Whether it’s a full chemical development cGMP program to get into clinical trials or a small ‘one-off’ analytical project, Solvias is ready to assist.


About RohnerChem: 


RohnerChem is a Swiss custom manufacturer specializing in the synthesis of complex molecules. Our core technologies include transition metal catalysis, enzymatic chemistry, high-pressure hydrogenations, carbonylations, low-temperature reactions, hydrazine handling and polymerisations. All laboratory and large scale manufacturing is carried out according to ISO up to cGMP standards.

About Dr. Felix Spindler: 

As Team Leader of the Catalysis Group, Dr. Spindler has directed the success of many customer projects and has co-authored more than 140 publications, patents and reviews. He was awarded the Sandmeyer Prize of the Swiss Chemical Society in 1998 and 2008 for contributions related to Ciba-Geigy’s S-Metolachlor process and DSM’s improved Biotin process. Dr. Spindler received his Ph.D. in 1982 from ETH Zurich with a thesis in the area of homogeneous hydrocarbonylation.

 
Contact:
For inquiries, please contact
Ronald Yarger at ronald.yarger@nullsolvias.com, or

Jim Schwindeman at james.schwindeman@nullrohnerchem.com
Top